Sentinel cerebral protection system
Boston Scientific’s Sentinel cerebral protection system is a percutaneously delivered, dual-filter embolic protection device.
Boston Scientific designed the device to capture and remove debris dislodged during endovascular and TAVR procedures. It has a 6 Fr catheter with deployable proximal and distal filters, an articulating sheath and an integral handle assembly.
Boston Scientific acquired the cerebral embolic protection system in 2018 with its $220 million acquisition of Claret Medical.
Sentinel was a nominee of Prix Galien’s best medical technology award in 2020.